Nature.comBiotech firm backs controversial CRISPR challengerNature.comA major enzyme manufacturer has signed an agreement with a Chinese university to explore uses for a protein claimed to be a powerful alternative to the popular genome-editing tool … Continue reading
Nature.comBiotech firms backs controversial CRISPR challengerNature.comA major enzyme manufacturer has signed an agreement with a Chinese university to explore uses for a protein claimed to be a powerful alternative to the popular genome-editing tool … Continue reading
|
Uncultivated microbes reveal new CRISPR–Cas systems
Nature.com The domestication of the class II CRISPR–Cas system has revolutionized molecular biology by allowing targeted editing of specific sequences in the genome. However, the CRISPR–Cas technologies currently in use are derived from isolated bacterial … |
|
Uncultivated microbes reveal new CRISPR–Cas systems
Nature.com The domestication of the class II CRISPR–Cas system has revolutionized molecular biology by allowing targeted editing of specific sequences in the genome. However, the CRISPR–Cas technologies currently in use are derived from isolated bacterial … |
Nature.com |
Cancer genomics Keeping score with immunotherapy response
Nature.com Immunotherapy has a substantial impact on the outcome of some cancers, but its potential is limited because only a minority of patients respond to treatment. Thus, a major motivation in the field is to identify ‘signatures’ that might predict with high … |
Charleston Post Courier |
The stem cell revolution is coming — slowly
Charleston Post Courier Shinya Yamanaka, who directs Kyoto University’s Center for iPS Cell Research and Application, in Tokyo, Jan. 13, 2017. Yamanaka, a 2012 Nobel Prize winner, says the revolutionary use of stem cells that will lead to powerful treatments for a range of … |
Science Daily |
Bodywide immune response important for fighting cancer …
Science Daily Effective anti-tumor activity requires a systemic, rather than only a local, immune response at the tumor site. The findings from a new study may help clinicians … New ‘immunoprofiler’ initiative will advance drug discovery …EurekAlert (press release) |
|
Scientists aim to create the world’s largest sickle cell disease stem cell library
Science Daily Scientists at the Center for Regenerative Medicine (CReM) at Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) are creating an induced pluripotent stem cell (iPSC)-based research library that opens the door to invaluable … |